RT @UrologyTimes: Dr. Alicia Morgans on how genomic testing and molecular markers are improving the landscape of advanced prostate cancer h…
NOTICE ON APCCC 2021 / 2022
The APC Executive Committee is highly conscientious of the impact that the current COVID-19 pandemic has on travel and event restrictions. We strongly believe in mitigating the spread of the virus while still maintaining the ability to facilitate the exchange between experts, and positively impact the lives of patients with advanced prostate cancer.
Therefore the APCCC 2022 is planned as a hybrid event. We will hold the conference as a face-to-face meeting, while providing the benefits of the conference in an online format. This opens opportunities for attendance to valuable experts from around the world, who may otherwise not be able to attend. Additionally, it provides us the flexibility to move to a completely virtual format, should a face-to-face meeting not be feasible.
Stay Connected
Find below our Twitter-Feed to get the hottest news.
RT @Silke_Gillessen: Great work, compliments to all for this important collaboration. @APCCC_Lugano https://t.co/tDb7a2FaWn
RT @EUplatinum: Cheng et al.: Pre-existing CRPC–like Cells in Primary Prostate Cancer Promote Resistance to Hormonal Therapy https://t.co/…
🤔 In which pts w/ synchronous #mHSPC that are chemotherapy fit do you recom. the triplet therapy ADT +docetaxel +abiraterone (in add. to ADT)? 1 In...
"How to take care of the heart?" 💙 Fred Saad will be discussing this topic in our session 5: The importance of lifestyle and prevention of...
What is the evidence of systemic therapies (alone or in combination with MDT) in each of the different subgroups? Mary-Ellen Taplin will be...